Implantation of paclitaxel-eluting stents in saphenous vein grafts: Clinical and angiographic follow-up results from a multicentre study

Heart

Volumn 93, Issue 3, 2007, Pages 331-334

  Hoffmann, Rainer ^a   Pohl, Tilmann ^b   Köster, Ralf ^c   Blindt, Ruediger ^a   Boeckstegers, Peter ^b   Heitzer, Thomas ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; METAL; PACLITAXEL;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FOLLOW UP; GRAFT OCCLUSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG IMPLANTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS;

EID: 34147197569     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.094722     Document Type: Article

References (22)

1. Fitzgibbon GM, Leach AJ, Kafka HP, et al. Coronary bypass graft fate: long term angiographic study. J Am Coll Cardiol 1991;17:1075-80.
2. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patients outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.
3. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-7.
4. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late out-comes after stent implantation in saphenous vein graft lesions: the multi-center U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995;26:704-12.
5. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1173-80.
6. Moses JJW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
7. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
8. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-45.
9. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. Circulation 1996;94:1247-54.
10. Gershlick A, De Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial. Circulation 2004;109:487-93.
11. Baim DS, Wahr D, George B, on behalf of the Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
12. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass graft. Circulation 2003;108:548-53.
13. Schachinger V, Hamm CW, Munzel T, et al. A randomized trial of polytetrafluoroehtylene-membrane covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003;42:1360-9.
14. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation 2003;108:37-42.
15. Waksman R, White RL, Chan RC, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002;346:1194-9.
16. Ge L, Iakovou I, Sangiorgi GM, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 2005;45:989-94.
17. Lee MS, Shah AP, Aragon J, et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. CatheterCardiovasc Interv 2005;66:507-11.
18. Tsuchida K, Ong ATL, Aoki J, et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 2005;96:395-8.
19. Chu WW, Rha SW, Kuchulakanti PK, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-7.
20. Lansky AJ, Costa RA, Mintz GS, et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 2004;109:1948-54.
21. Elezi S, Kastrati A, Neumann FJ, et al. Vessel size and long-term outcome after coronary stent placment. Circulation 1998;98:1875-80.
22. Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 2006;113:2293-300.